# Perspective Therapeutics, Inc. (CATX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Perspective Therapeutics, Inc. (CATX) is 5/100, ranked against 24,000+ stocks in 35 markets (Quality 21, Value 33, Momentum 18, each scored against its sector).

- StockRank: 5/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 21, Value 33, Momentum 18: each a 0-100 percentile within Healthcare.
- Position: #25,228 overall, #2,498 in Healthcare.
- Listing: United States, ASE; Healthcare / Medical Devices.
- Last close: 1.21 USD on 26 Oct 2026.
- Insider filings, last 180 days: 5%+ holders sold USD 1.4M.

Source: https://moatmap.ai/stock/CATX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker